Acid-Base Imbalance: Clinical Trials

33 trials for Acid-Base Imbalance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 4 recruiting, 4 terminated, 3 not yet recruiting. 33 Phase 1, 11 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 133Completed 16, Recruiting 4, Terminated 4, Not yet recruiting 3, Unknown 2, Withdrawn 2, Active not recruiting 1, Suspended 1
Phase 211Recruiting 4, Completed 3, Not yet recruiting 2, Terminated 1, Withdrawn 1

Follow Acid-Base Imbalance: new trials by email Literature Review of Acid-Base Imbalance trials Research Report on Acid-Base Imbalance

Trials (filtered) newest first · largest first

All 33 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)
Glycerol Tributyrate - MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)
Phase 1 / Phase 2Not yet recruitingGeorge Washington University242027-03-012026-10-05
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PAL-119 in Healthy Volunteers and Adult Participants With Type 1 or Type 2 Diabetes
PAL-119, Placebo - Healthy Volunteers and Diabetes Participants
Phase 1 / Phase 2Not yet recruitingPaulex Bio Inc.1472026-11-012026-10-28
Phase 1 Trial of Arginine Hydrochloride for the Management of Diabetic Ketoacidosis in Type 2 Diabetes
Arginine hydrochloride, Sodium Chloride 0.9% - Diabetes (DM), Diabetic Ketoacidosis
Phase 1 / Phase 2RecruitingDavid K Carroll602025-12-192026-02-12
Impact of Exogenous Ketones on Sleep and Breathing in Healthy Volunteers (K-SLEEP)
KETONE-IQ 20 grams (g), KETONE-IQ 40 grams (g) - Healthy Participants, Sleep
Phase 1CompletedJohns Hopkins University202025-12-182026-09-28
Investigating the Evolutionary Impact of Metabolic Flexibility on Physical Activity-Dependent BDNF and Cognition: Insights From the Val66Met Polymorphism
d-beta-hydroxybutrate, Placebo - Cognition, BDNF
Phase 1Not yet recruitingUniversity of Southern California502025-11-012025-10-20
Adding Urea to the Final Dialysis Fluid
Urea in the dialysate - Dysequilibrium Syndrome, ESRD
Phase 1 / Phase 2RecruitingUniversity of California, San Francisco202025-09-162026-02-12
Impact of Exogenous Ketones on Sleep Apnea
Ketone-IQ, Placebo - Obstructive Sleep Apnea, Sleep
Phase 1 / Phase 2WithdrawnJohns Hopkins University2025-01-292026-09-21
Impact of Exogenous Ketones on Sleep Disruption in Vulnerable Populations
Ketone-IQ (1,3 Butanediol) - Obstructive Sleep Apnea, Sleep
Phase 1SuspendedJohns Hopkins University302025-01-292026-06-23
the Effect of Interdialytic Serum Bicarbonate Correction on Vascular Calcification in Hemodialysis Patients
Oral sodium bicarbonate - End Stage Renal Disease (ESRD), Metabolic Acidosis
Phase 1CompletedAin Shams University402023-09-012026-08-14
Ketone Pharmacokinetic Study in HFrEF
DeltaG (250 mg/kg), DeltaG (500 mg/kg) - Heart Failure With Reduced Ejection Fraction
Phase 1CompletedDuke University202023-06-022024-12-27
Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers
SGLT2 inhibitor, Controlled, Adaptive Study Diet - Ketones, Metabolism
Phase 1Active not recruitingAdventHealth Translational Research Institute92023-03-162026-03-30
Study to Explore the Effect of Dapagliflozin and Stress in Adolescent and Adult Subjects With Type 1 Diabetes (T1D)
Dapagliflozin, Placebo oral tablet, Stress - Type 1 Diabetes, Diabetic Ketoacidosis
Phase 1TerminatedKinderkrankenhaus auf der Bult22022-05-182024-12-09
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
mRNA-3927 - Propionic Acidemia
Phase 1 / Phase 2RecruitingModernaTX, Inc.502021-11-092026-03-23
Assessment of Gastric pH Changes Induced by Ascorbic Acid Tablets
Omeprazole 20mg, Vitamin C - Hypochlorhydria
Phase 1CompletedIndiana University112021-10-012025-09-22
Study to Evaluate Effects of Food or Proton Pump Inhibitor on the Pharmacokinetics of Itraconazole in Healthy Volunteers
Itraconazole 200 mg, Esomeprazole 40 mg - Achlorhydria
Phase 1CompletedSeoul National University Hospital132021-07-132021-09-29
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
mRNA-3927 - Propionic Acidemia
Phase 1 / Phase 2RecruitingModernaTX, Inc.772021-04-152026-01-22
Nutritional Ketosis in Heart Failure
beta hydroxybutyrate (BHB) ester, Placebo - Chronic Heart Failure
Phase 1UnknownThomas Jefferson University162020-06-012020-05-01
Sodium-glucose Co Transporter 2 (sGLT2) Inhibitor and Endogenous Ketone Production
empagliflozin (Jardiance) 25 mg - Empaglifozin, Physiological Effects of Drugs
Phase 1CompletedNational Institute on Aging (NIA)212019-03-282022-08-02
Effects of Ketone Bodies on Cognition in Type 2 Diabetes
Ketone infusion, Saline infusion - Type2 Diabetes, Ketonemia
Phase 1CompletedBispebjerg Hospital182018-09-172019-02-20
Exogenous Ketones and Glucose Tolerance
Ketone monoester, Placebo - Ketones, Dietary Supplements
Phase 1CompletedUniversity of British Columbia152018-03-262019-04-18

Showing 20 of 33. Sign in to see all of them.

Narrower conditions

Ketosis (17)  ·  Acidosis (7)  ·  Diabetes Mellitus, Type 1 (3)  ·  Diabetic Ketoacidosis (3)  ·  Achlorhydria (2)  ·  Acidosis, Lactic (2)  ·  Alzheimer Disease (2)  ·  Amino Acid Metabolism, Inborn Errors (2)  ·  Diabetes Mellitus (2)  ·  Genetic Diseases, Inborn (2)  ·  Hyperglycemia (2)  ·  Insulin Resistance (2)  ·  Kidney Failure, Chronic (2)  ·  Metabolic Diseases (2)

Broader conditions

Nutritional and Metabolic Diseases (33)  ·  Metabolic Diseases (31)  ·  Acidosis (23)  ·  Pathological Conditions, Signs and Symptoms (12)  ·  Nervous System Diseases (11)  ·  Brain Diseases (9)  ·  Central Nervous System Diseases (9)  ·  Glucose Metabolism Disorders (6)  ·  Pathologic Processes (6)  ·  Signs and Symptoms (6)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (5)  ·  Female Urogenital Diseases (5)  ·  Female Urogenital Diseases and Pregnancy Complications (5)  ·  Male Urogenital Diseases (5)

Interventions

Sodium Bicarbonate (2)  ·  1,3-butylene glycol (1)  ·  3-Hydroxybutyric Acid (1)  ·  Arginine (1)  ·  Ascorbic Acid (1)  ·  Biguanides (1)  ·  Colloids (1)  ·  Control Groups (1)  ·  Crystalloid Solutions (1)  ·  Diet (1)  ·  Diet, Carbohydrate-Restricted (1)  ·  Diet, Diabetic (1)  ·  Diet, Sodium-Restricted (1)  ·  Endothelium-Dependent Relaxing Factors (1)  ·  Esomeprazole (1)

Sponsors

Johns Hopkins University (6)  ·  ModernaTX, Inc. (2)  ·  AdventHealth Translational Research Institute (1)  ·  Ain Shams University (1)  ·  Albert Einstein College of Medicine (1)  ·  Bispebjerg Hospital (1)  ·  Burke Rehabilitation Hospital (1)  ·  David K Carroll (1)  ·  Duke University (1)  ·  George Washington University (1)  ·  GlaxoSmithKline (1)  ·  Indiana University (1)  ·  Kinderkrankenhaus auf der Bult (1)  ·  Mallinckrodt (1)  ·  National Institute on Aging (NIA) (1)

Countries

United States (21)  ·  United Kingdom (4)  ·  Canada (3)  ·  Denmark (2)  ·  France (2)  ·  Japan (2)  ·  Netherlands (2)  ·  Saudi Arabia (2)  ·  Spain (2)  ·  Bulgaria (1)  ·  Egypt (1)  ·  Georgia (1)  ·  Germany (1)  ·  Israel (1)  ·  South Korea (1)

Top investigators

Jonathan Jun, MD (3)  ·  Eric H Kossoff, MD (2)  ·  Anne Chiaramello, Ph.D. (1)  ·  Carolin I Dohle, MD (1)  ·  Debra Regier, M.D., Ph.D. (1)  ·  Dileep Lobo, MBBS MD FRCS (1)  ·  J. Eduardo Rame, M.D. (1)  ·  Jane Little, MD (1)  ·  Jens Rikardt Andersen, MD (1)  ·  Jinesh Mehta, MD (1)  ·  Josephine M Egan, M.D. (1)  ·  Matthew K Abramowitz, MD, MS (1)  ·  Melissa Erickson, PhD (1)

Results publications

PMID 19183804, PMID 22580944, PMID 29102959, PMID 31599919, PMID 36577040, PMID 40139871

NIH funding

2009 (1), 2015 (1), K23HL161348 (1), UH3TR003897 (1)